CARTPT and neoplasm: In summary, an increased number of CART as well as other immune cells were detected in tumor of IMSA101 + CART-treated syngeneic mice, indicating that IMSA101 remodels the TIME, supporting trafficking of CART and other immune cells into the tumor.